AU619481B2 - Oral magnesium and potassium compositions and use - Google Patents

Oral magnesium and potassium compositions and use Download PDF

Info

Publication number
AU619481B2
AU619481B2 AU22043/88A AU2204388A AU619481B2 AU 619481 B2 AU619481 B2 AU 619481B2 AU 22043/88 A AU22043/88 A AU 22043/88A AU 2204388 A AU2204388 A AU 2204388A AU 619481 B2 AU619481 B2 AU 619481B2
Authority
AU
Australia
Prior art keywords
potassium
magnesium
milliequivalent
bioavailable
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU22043/88A
Other languages
English (en)
Other versions
AU2204388A (en
Inventor
Frederick J. Dechow
Pravin B. Sheth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of AU2204388A publication Critical patent/AU2204388A/en
Application granted granted Critical
Publication of AU619481B2 publication Critical patent/AU619481B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU22043/88A 1987-09-11 1988-09-09 Oral magnesium and potassium compositions and use Expired - Fee Related AU619481B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9575087A 1987-09-11 1987-09-11
US095750 1987-09-11

Publications (2)

Publication Number Publication Date
AU2204388A AU2204388A (en) 1989-03-16
AU619481B2 true AU619481B2 (en) 1992-01-30

Family

ID=22253423

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22043/88A Expired - Fee Related AU619481B2 (en) 1987-09-11 1988-09-09 Oral magnesium and potassium compositions and use

Country Status (12)

Country Link
JP (1) JPH01100128A (it)
AU (1) AU619481B2 (it)
BE (1) BE1001842A3 (it)
CH (1) CH677612A5 (it)
DE (1) DE3830563A1 (it)
DK (1) DK501288A (it)
FR (1) FR2620334A1 (it)
GB (1) GB2209668B (it)
IT (1) IT1227010B (it)
LU (1) LU87331A1 (it)
NL (1) NL8802224A (it)
SE (1) SE8803125L (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990015611A1 (en) * 1989-06-20 1990-12-27 Otsuka Pharmaceutical Co., Ltd. Potassium-supplementing preparation
US5132118A (en) * 1990-05-11 1992-07-21 Mills John A Treatment of exercise-induced pulmonary hemorrhage in animals
FI911038A (fi) * 1991-03-01 1992-09-02 Slk Marketing Oy Dryckpulver.
US5460972A (en) * 1991-04-08 1995-10-24 Research Foundation Of The State University Of New York Ionized magnesium2+ concentrations in biological samples
FR2677546B1 (fr) * 1991-06-12 1994-01-21 Fabienne Joanny Composition therapeutique pour liberation prolonge de magnesium.
DE4201504C2 (de) * 1992-01-21 1997-04-30 Protina Chemische Ges Mbh Magnesiumpräparat
CN1090483C (zh) * 1997-07-31 2002-09-11 谢理峰 钾镁缓释片及生产方法
DE10158286B4 (de) * 2000-11-20 2007-08-02 Dehn, Michael C. Wirkstoffspeicherndes Schichtmaterial
DE10126405A1 (de) * 2001-05-22 2003-02-27 Trommsdorff Gmbh & Co Physiologisch verträgliche Kalium- und Magnesiumsalze enthaltendes pharmazeutisches Präparat sowie dessen Verwendung zur Prophylaxe und/oder Therapie von QT-Zeitverlängerungen
EP1762231B1 (de) * 2005-08-19 2010-10-27 Verla-Pharm Arzneimittelfabrik Apotheker H.J. von Ehrlich GmbH & Co. KG Magnesium-Mikrotabletten mit verzögerter Freisetzung

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1356097A (en) * 1972-02-25 1974-06-12 Hoffmann La Roche Mineral salt preparation
GB1422193A (en) * 1974-07-26 1976-01-21 Smith Kline French Lab Pharmaceutical compositions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1356097A (en) * 1972-02-25 1974-06-12 Hoffmann La Roche Mineral salt preparation
GB1422193A (en) * 1974-07-26 1976-01-21 Smith Kline French Lab Pharmaceutical compositions

Also Published As

Publication number Publication date
CH677612A5 (it) 1991-06-14
IT8848327A0 (it) 1988-09-08
GB2209668B (en) 1991-06-05
FR2620334A1 (fr) 1989-03-17
DK501288A (da) 1989-03-12
LU87331A1 (fr) 1989-10-26
IT1227010B (it) 1991-03-05
BE1001842A3 (fr) 1990-03-20
SE8803125L (sv) 1989-03-12
GB2209668A (en) 1989-05-24
SE8803125D0 (sv) 1988-09-06
JPH01100128A (ja) 1989-04-18
GB8821056D0 (en) 1988-10-05
DK501288D0 (da) 1988-09-09
AU2204388A (en) 1989-03-16
DE3830563A1 (de) 1989-03-30
NL8802224A (nl) 1989-04-03

Similar Documents

Publication Publication Date Title
US4424235A (en) Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor
ES2226886T3 (es) Forma de administracion de accion retardada que contiene sacarinato de tramadol.
US5505962A (en) Controlled release pharmaceutical formulation
US5540945A (en) Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
US5397574A (en) Controlled release potassium dosage form
PL129290B1 (en) Method of obtaining new forms of dipyridamole exhibiting prolonged action
US4954349A (en) Oral magnesium and potassium compositions and use
AU2010289022B2 (en) New compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine
CA2025714A1 (en) Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
SI8710681A8 (en) Process for obtaining new pharmaceutic substance for oral use
WO1991006281A1 (en) Gastric preparation
JPS6357523A (ja) 徐放性錠剤
AU619481B2 (en) Oral magnesium and potassium compositions and use
GB2105590A (en) Flotable controlled release preparations
JPH06279274A (ja) 懸濁液徐放性製薬組成物
EP0425699B1 (en) Oral preparation which can be released at suitable region in intestine
GB2134785A (en) Slow-release compositions
EP2029105A1 (en) Phenylphrine pulsed release formulations and pharmaceutical compositions
JPH02240016A (ja) 水分散性ジエムフイブロジル組成物
US3066075A (en) Compositions comprising amphetamine and carboxymethyl cellulose in chemically combined form
EP0121901A1 (en) pH independent controlled releasable tablets
AU2005264864A1 (en) Multiple PPI dosage form
CN106466302B (zh) 口服氯化钾缓释片及其制备方法
JPH0747534B2 (ja) 錠 剤
IE852069L (en) Sustained release tablets